Article
Endocrinology & Metabolism
Lu Zhang, Gui Ping Zhang, Wei Wei Zhan, Wei Zhou
Summary: This study evaluated the feasibility and efficacy of percutaneous laser ablation (PLA) for patients with multifocal papillary thyroid microcarcinoma (PTMC). The results showed that PLA is a safe and effective technique for treating multifocal PTMC, which might be an alternative technique for patients who are not eligible or are unwilling to undergo surgery.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Endocrinology & Metabolism
Zhang Juan, Yongping Liang, Xiaochen Han, Zhiwu Wang, Jingping Liu, Yongfeng Zhao, Wengang Liu, Ping Zhou
Summary: Ultrasound-guided percutaneous laser ablation (PLA) is effective and safe for the treatment of elderly patients with papillary thyroid microcarcinoma (PTMC) who are ineligible for surgery, resulting in complete disappearance or scar-like changes of the ablation lesions.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Surgery
Lin Yan, Ying Liu, WenHui Li, YaLin Zhu, Jinling Wang, Mingbo Zhang, Jie Tang, Ying Che, Hui Wang, Shurong Wang, Yukun Luo
Summary: This study found that ultrasound-guided thermal ablation is an effective and safe treatment option for patients with solitary low-risk papillary thyroid microcarcinoma, based on a retrospective multicenter cohort with more than 5-year follow-up.
Article
Radiology, Nuclear Medicine & Medical Imaging
Xinyang Li, Lin Yan, Jing Xiao, Yingying Li, Zhen Yang, Mingbo Zhang, Yukun Luo
Summary: This study aimed to define a response-to-ablation system based on dynamic risk stratification in order to predict clinical outcomes and guide follow-up strategies for patients with low-risk PTMC who underwent RFA. The study found that the system effectively predicted the risk of LTP and guided ongoing follow-up recommendations, providing a new paradigm for the management of PTMC patients.
EUROPEAN RADIOLOGY
(2023)
Review
Radiology, Nuclear Medicine & Medical Imaging
Se Jin Cho, Sun Mi Baek, Dong Gyu Na, Kang Dae Lee, Young Kee Shong, Jung Hwan Baek
Summary: Thermal ablation is an excellent method for local tumor control in low-risk PTMC patients, with low rates of major complications at 5 years.
EUROPEAN RADIOLOGY
(2021)
Article
Endocrinology & Metabolism
Jing Xiao, Yan Zhang, Lin Yan, Mingbo Zhang, Xinyang Li, Jie Tang, Yukun Luo
Summary: Objective Ultrasonography-guided radiofrequency ablation (RFA) is a viable alternative to surgery for treating T1aN0M0 and T1bN0M0 papillary thyroid carcinoma (PTC), yielding similar outcomes in terms of local tumor progression and survival rates.
EUROPEAN JOURNAL OF ENDOCRINOLOGY
(2022)
Article
Oncology
Xinya Wang, Xiaoyan Niu, Shuang Mu, Mingzhu Zhang, Wenbin Jiang, Lixue Zhai, Danni Jiang, Wanqing Tang, Cheng Zhao
Summary: Ultrasound-guided MWA is an effective treatment strategy for unifocal PTMC with a diameter of <= 0.6cm. The volume of nodules significantly decreased in the MWA group after treatment, with lower rates of complications than surgery, and shorter operating room time and hospital stay.
INTERNATIONAL JOURNAL OF HYPERTHERMIA
(2021)
Article
Endocrinology & Metabolism
Lin Yan, Mingbo Zhang, Qing Song, Yukun Luo
Summary: This study compared the clinical outcomes of radiofrequency ablation (RFA) versus thyroid lobectomy (TL) for low-risk papillary thyroid microcarcinoma (PTMC) and found comparable results in a four-year follow-up period. RFA, as a minimally invasive modality, may be a promising alternative treatment option for low-risk PTMC patients.
Article
Endocrinology & Metabolism
Ho Jin Kim, Seung Min Chung, Hanbyul Kim, Ju Young Jang, Jae Hong Yang, Jun Sung Moon, Gitak Son, Jong-Ryool Oh, Jong Yup Bae, Hyundae Yoon
Summary: This study evaluated the 10-year efficacy and safety of laser ablation (LA) for the treatment of solitary papillary thyroid microcarcinoma (PTMC). The results showed that LA was well tolerated by patients, with a disappearance rate of 100% in ablation areas after 12 months. Thyroid hormone and autoantibody levels did not significantly change post-treatment, and the majority of patients did not experience recurrence. For those with recurrence, surgery was performed successfully.
Article
Endocrinology & Metabolism
Giovanni Mauri, Franco Orsi, Serena Carriero, Paolo Della Vigna, Elvio De Fiori, Dario Monzani, Gabriella Pravettoni, Enrica Grosso, Marco F. Manzoni, Mohssen Ansarin, Gioacchino Giugliano
Summary: The study presented the results of treating 11 patients with papillary thyroid microcarcinoma using image-guided thermal ablation, achieving a 100% technical success rate and reduction in ablated volume from preoperative planning to follow-up. There were no recurrences during the follow-up period, and patients expressed high satisfaction and low pain perception during and after the procedure.
FRONTIERS IN ENDOCRINOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Lin Yan, Mingbo Zhang, Qing Song, Fang Xie, Yukun Luo
Summary: The impact of multifocality on the prognosis after RFA for low-risk PTMC was minimal, indicating that RFA may be a promising treatment for both unifocal and multifocal PTMC in properly selected patients after sufficient preoperative evaluation.
EUROPEAN RADIOLOGY
(2022)
Review
Endocrinology & Metabolism
Zhiguang Chen, Wei Zhang, Wen He
Summary: This systematic review examines the indications, efficacy, and safety of thermal ablation (TA) in the treatment of papillary thyroid microcarcinoma (PTMC). The findings suggest that TA is an effective alternative to surgery for low-risk PTMC, offering minimally invasive treatment, cost-effectiveness, minimal bleeding, and improved postoperative quality of life.
CLINICAL ENDOCRINOLOGY
(2023)
Article
Oncology
Lin Yan, Yingying Li, Xin Yang Li, Jing Xiao, Jie Tang, Yukun Luo
Summary: This study aimed to evaluate the clinical outcomes of ultrasound-guided radiofrequency ablation (RFA) for solitary T1N0M0 papillary thyroid carcinoma (PTC) patients. The results showed that RFA is an effective and safe alternative for patients who refuse surgery or active surveillance.
Article
Hematology
Chao Zhang, Jing Yin, Chenlu Hu, Qin Ye, Ping Wang, Pintong Huang
Summary: This study compared the efficacy, safety and costs of ultrasound guided percutaneous radiofrequency ablation (RFA) with open thyroidectomy for treating low-risk papillary thyroid microcarcinoma (PTMC). The results showed that RFA was effective and safe, with a higher rate of tumor disappearance, shorter operation time and hospital stay, lower hospitalization expenses, and better cosmetic results than surgery.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
(2022)
Review
Oncology
JiaNan Xue, DengKe Teng, Hui Wang
Summary: Through a systematic review and meta-analysis, this study found that US-guided radiofrequency ablation (RFA) is significantly effective and safe for treating papillary thyroid microcarcinoma (PTMC), and could be an excellent alternative to existing treatment options.
INTERNATIONAL JOURNAL OF HYPERTHERMIA
(2022)
Article
Biotechnology & Applied Microbiology
Wengang Liu, Ping Zhou, Yongfeng Zhao, Shuangming Tian, Xiaomin Wu
BIOMED RESEARCH INTERNATIONAL
(2018)
Article
Biotechnology & Applied Microbiology
Xingxing Duan, Ya Peng, Wengang Liu, Liu Yang, Jie Zhang
BIOMED RESEARCH INTERNATIONAL
(2019)
Article
Medical Informatics
Liang Yongping, Zhang Juan, Ping Zhou, Zhao Yongfeng, Wengang Liu, Yifan Shi
JMIR MEDICAL INFORMATICS
(2020)
Article
Medical Informatics
Liang Yongping, Ping Zhou, Zhang Juan, Zhao Yongfeng, Wengang Liu, Yifan Shi
JMIR MEDICAL INFORMATICS
(2020)